Education
About Us
Working with TipRanks
Follow Us
BioCorRx (BICX)
:BICX
BICX Stock Chart & Stats
$0.40
$0.00(0.00%)
At close: 4:00 PM EST
$0.40
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.20 - $1.45
Previous CloseN/A
Volume44.00
Average Volume (3M)806.00
Market Cap
$8.29M
Enterprise Value$13.26M
Total Cash (Recent Filing)$287.69K
Total Debt (Recent Filing)$2.78M
Price to Earnings (P/E)―
Beta0.50
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding23,685,343
10 Day Avg. Volume1,260
30 Day Avg. Volume806
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)-0.33
Price to Sales (P/S)518.78
P/FCF Ratio-3.63
Enterprise Value/Market Cap1.60
Enterprise Value/Revenue13.12
Enterprise Value/Gross Profit38.95
Enterprise Value/Ebitda-4.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.25
Revenue Forecast (FY)$696.30K
BioCorRx News
BICX FAQ
What was BioCorRx’s price range in the past 12 months?
BioCorRx lowest stock price was $0.20 and its highest was $1.45 in the past 12 months.
What is BioCorRx’s market cap?
BioCorRx’s market cap is $8.29M.
When is BioCorRx’s upcoming earnings report date?
BioCorRx’s upcoming earnings report date is Aug 17, 2026 which is in 241 days.
How were BioCorRx’s earnings last quarter?
BioCorRx released its earnings results on Aug 14, 2025. The company reported -$0.07 earnings per share for the quarter, the consensus estimate of -$0.07 by $0.
Is BioCorRx overvalued?
According to Wall Street analysts BioCorRx’s price is currently Overvalued.
Does BioCorRx pay dividends?
BioCorRx does not currently pay dividends.
What is BioCorRx’s EPS estimate?
BioCorRx’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BioCorRx have?
BioCorRx has 23,685,343 shares outstanding.
What happened to BioCorRx’s price movement after its last earnings report?
BioCorRx reported an EPS of -$0.07 in its last earnings report, expectations of -$0.07. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of BioCorRx?
Currently, no hedge funds are holding shares in BICX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
BioCorRx
BioCorRx Inc. is a healthcare solutions company operating primarily in the substance use disorder treatment sector. The company offers a range of products and services aimed at combating addiction, including a proprietary implantable naltrexone pellet for alcohol and opioid use disorders. Their offerings are designed to support individuals in their recovery journey through a combination of medical intervention and behavioral therapy programs.
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
Cryo-Cell International
―
Oncology Institute
―
COMPASS Pathways
―
Ownership Overview
Options Prices
Currently, No data available
---